단백질 마이크로어레이 시장(2026-2030년)

The global protein microarray market is forecasted to grow by USD 1306.2 mn during 2025-2030, accelerating at a CAGR of 7.2% during the forecast period. The report on the global protein microarray market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in proteomics research and biomarker discovery, rising integration of personalized medicine and companion diagnostics, technological innovations and platform automation in high-throughput screening.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global protein microarray market is segmented as below:

By Class Type

• Analytical protein microarrays
• Functional protein microarrays

By Application

• Proteomics
• Diagnostics
• Others

By End-User

• Pharmaceutical companies
• Diagnostic laboratories
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the shift toward high-density next-generation multiomics and hybrid proteomic integration as one of the prime reasons driving the global protein microarray market growth during the next few years. Also, expansion of machine learning and ai-driven bioinformatics pipelines and transition from exploratory proteomics to automated regulated clinical diagnostics will lead to sizable demand in the market.

The report on the global protein microarray market covers the following areas:

• Global protein microarray market sizing
• Global protein microarray market forecast
• Global protein microarray market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global protein microarray market vendors that include Antigen Discovery Inc., Arrayjet Ltd., Boao Bio Group Co. Ltd., Cambridge Protein Arrays Ltd., CD Genomics, CDI Laboratories Inc., Creative Biolabs, Full Moon BioSystems Inc., ImmunoSign Inc., Merck KGaA, Ordinatrix, OriGene Technologies Inc., PEPperPRINT GmbH, PerkinElmer US LLC, Protein Biotechnologies Inc., RayBiotech Life Inc., SCHOTT AG, Standard BioTools Inc., Thermo Fisher Scientific Inc.. Also, the global protein microarray market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Class Type
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Protein Microarray Market 2020 - 2024
  • Historic Market Size - Data Table on Global Protein Microarray Market 2020 - 2024 ($ million)
• 5.2 Class Type segment analysis 2020 - 2024
  • Historic Market Size - Class Type Segment 2020 - 2024 ($ million)
• 5.3 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Protein Microarray Market
• 6.2 Impact of Geopolitical Conflicts on Global Protein Microarray Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Class Type

• 8.1 Market segments
• 8.2 Comparison by Class Type
• 8.3 Analytical protein microarrays - Market size and forecast 2025-2030
• 8.4 Functional protein microarrays - Market size and forecast 2025-2030
• 8.5 Market opportunity by Class Type
  • Market opportunity by Class Type ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Proteomics - Market size and forecast 2025-2030
• 9.4 Diagnostics - Market size and forecast 2025-2030
• 9.5 Others - Market size and forecast 2025-2030
• 9.6 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Pharmaceutical companies - Market size and forecast 2025-2030
• 10.4 Diagnostic laboratories - Market size and forecast 2025-2030
• 10.5 Others - Market size and forecast 2025-2030
• 10.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Singapore - Market size and forecast 2025-2030
  • 12.5.6 Taiwan - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 South Africa - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Turkey - Market size and forecast 2025-2030
  • 12.6.7 Egypt - Market size and forecast 2025-2030
  • 12.6.8 Chile - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Advancements in proteomics research and biomarker discovery
  • Rising integration of personalized medicine and companion diagnostics
  • Technological innovations and platform automation in high-throughput screening
• 13.2 Market challenges
  • Technical complexity in maintaining protein native conformation and assay stability
  • High operational costs and capital expenditure constraints
  • Bioinformatics bottlenecks and complex data interpretation
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Shift toward high-density next-generation multiomics and hybrid proteomic integration
  • Expansion of machine learning and AI-driven bioinformatics pipelines
  • Transition from exploratory proteomics to automated regulated clinical diagnostics

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Antigen Discovery Inc.
  • Antigen Discovery Inc. - Overview
  • Antigen Discovery Inc. - Product / Service
  • Antigen Discovery Inc. - Key offerings
  • SWOT
• 15.5 Arrayjet Ltd.
  • Arrayjet Ltd. - Overview
  • Arrayjet Ltd. - Product / Service
  • Arrayjet Ltd. - Key offerings
  • SWOT
• 15.6 Boao Bio Group Co. Ltd.
  • Boao Bio Group Co. Ltd. - Overview
  • Boao Bio Group Co. Ltd. - Product / Service
  • Boao Bio Group Co. Ltd. - Key offerings
  • SWOT
• 15.7 Cambridge Protein Arrays Ltd.
  • Cambridge Protein Arrays Ltd. - Overview
  • Cambridge Protein Arrays Ltd. - Product / Service
  • Cambridge Protein Arrays Ltd. - Key offerings
  • SWOT
• 15.8 CD Genomics
  • CD Genomics - Overview
  • CD Genomics - Product / Service
  • CD Genomics - Key offerings
  • SWOT
• 15.9 CDI Laboratories Inc.
  • CDI Laboratories Inc. - Overview
  • CDI Laboratories Inc. - Product / Service
  • CDI Laboratories Inc. - Key offerings
  • SWOT
• 15.10 Creative Biolabs
  • Creative Biolabs - Overview
  • Creative Biolabs - Product / Service
  • Creative Biolabs - Key offerings
  • SWOT
• 15.11 Full Moon BioSystems Inc.
  • Full Moon BioSystems Inc. - Overview
  • Full Moon BioSystems Inc. - Product / Service
  • Full Moon BioSystems Inc. - Key offerings
  • SWOT
• 15.12 ImmunoSign Inc.
  • ImmunoSign Inc. - Overview
  • ImmunoSign Inc. - Product / Service
  • ImmunoSign Inc. - Key offerings
  • SWOT
• 15.13 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.14 Ordinatrix
  • Ordinatrix - Overview
  • Ordinatrix - Product / Service
  • Ordinatrix - Key offerings
  • SWOT
• 15.15 OriGene Technologies Inc.
  • OriGene Technologies Inc. - Overview
  • OriGene Technologies Inc. - Product / Service
  • OriGene Technologies Inc. - Key offerings
  • SWOT
• 15.16 PerkinElmer US LLC
  • PerkinElmer US LLC - Overview
  • PerkinElmer US LLC - Product / Service
  • PerkinElmer US LLC - Key offerings
  • SWOT
• 15.17 SCHOTT AG
  • SCHOTT AG - Overview
  • SCHOTT AG - Product / Service
  • SCHOTT AG - Key offerings
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations